Amgen Inc (NASDAQ:AMGN)

220.86
Delayed Data
As of Nov 15
 +2.36 / +1.08%
Today’s Change
166.30
Today|||52-Week Range
225.26
+13.45%
Year-to-Date
AMGN Regular Dividend: AMGN began trading ex-dividend on 11/14/19. A $1.45 dividend will be paid to shareholders of record as of 11/15/19.
Amarin's Stock Could Reach $50 Per Share Soon
Nov 13 / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Nov 09 / MotleyFool.com - Paid Partner Content
Here’s Why FibroGen’s Stock Popped Friday
Nov 11 / MotleyFool.com - Paid Partner Content
Here's Why Cytokinetics Stock Tanked on Thursday
Nov 07 / MotleyFool.com - Paid Partner Content
Why Amgen's Stock Soared in October
Nov 11 / MotleyFool.com - Paid Partner Content
Buy These 2 Stocks to Access China's Huge Healthcare Market
Nov 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close218.50
Today’s open219.59
Day’s range217.21 - 220.93
Volume2,028,585
Average volume (3 months)2,831,902
Market cap--
Data as of 4:15pm ET, 11/15/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)+0.15%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+4.32%
P/E ratio17.0
Price/Sales5.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.26+1.97%
BIIBBiogen+7.12+2.59%
ILMNIllumina Inc+7.55+2.53%
BMRNBiomarin Pharmaceuti...-0.54-0.71%
Data as of 4:15pm ET, 11/15/2019

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$3.25
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts